MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Parkinson’s disease in Middle East, North Africa and South Asia: Consensus from the MDS Task Force on the Middle East

    H. Khalil, L. Chahine, J. Junaid Siddiqui, M. Salari, S. El-Jaafary, Z. Aldaajani, M. Abu Al-Melh, T. Mohammad, M. Abu Snineh, N. Syed, M. Bhatt, M. Habib, M. Habahbeh, S. Tabbal, B. Jeon, J. Bajwa (Irbid, Jordan)

    Objective: To create a list of needs and priorities in the advancement of the Movement Disorders field in general and Parkinson’s disease care in specific…
  • 2019 International Congress

    Communication Calendar for Interdisciplinary Therapy of Parkinson’s Disease

    F. Adib Saberi, D. Dressler (Hamburg, Germany)

    Objective: To develop a communication calendar (CC) to facilitate information exchange amongst therapists involved in interdisciplinary therapy of Parkinson's Disease (PD). Background: Increasing complexity of…
  • 2019 International Congress

    An outlook: Palliative care for patients with Parkinsonism syndrome

    MI. Arain (Jamshoro, Pakistan)

    Objective: The main purpose of  study is to provide interventions and highlight the assessment of supportive care needs in Parkinson’s disease. Background: A clinical syndrome…
  • 2019 International Congress

    Carrier Mediated Delivery System Bearing Dopamine for Effective Management of Parkinsonism

    M. Bhargava, S. Bhargava (Kanpur, India)

    Objective: In the present investigation, amino acid coupled liposomes bearing dopamine-HCl were prepared to deliver drug to the brain utilizing receptor-mediated transcytosis for effective management…
  • 2019 International Congress

    To compare early / late onset MSA from the PAN American MSA (PANMSA) database

    M. Cesarini, E. Gatto, J. Etcheverry, G. da Prat, F. Peralta (Caba, Argentina)

    Objective: Compare two different cohorts of patients with the same pathology differentiated by age of onset. Background: Multiple system atrophy (MSA) is a rare neurodegenerative…
  • 2019 International Congress

    Comprehensive clinico-pathophysiological assessment of constipation in Parkinson’s disease

    E. de Pablo-Fernandez, V. Passananti, N. Zárate-López, A. Emmanuel, T. Warner (London, United Kingdom)

    Objective: To perform a comprehensive assessment of constipation in Parkinson’s disease (PD) using various complementary diagnostic techniques to elucidate its pathophysiology and improve its symptomatic…
  • 2019 International Congress

    Dysregulated long non-coding RNA in Parkinson’s disease contributes to the apoptosis of dopaminergic neuron

    Y. Fan, Z. Xue (Wuhan, China)

    Objective: The study aims to explore the expression profiles of lncRNA of PD patients and its roles to the pathogenesis of PD. Background: The molecular…
  • 2019 International Congress

    The effect of coexistent neurodegenerative disorders on the clinical features of idiopathic normal pressure hydrocephalus

    A. Hattori, T. Tsunemi, N. Hattori (Bunkyo-Ku, Japan)

    Objective: To determine the prevalence of neurodegenerative disorders in idiopathic normal pressure hydrocephalus (iNPH) and their effects on the clinical features of iNPH. Background: To…
  • 2019 International Congress

    No difference in balance and gait parameters of the patients with akinetic-rigid and tremor-dominant Parkinson’s disease

    AC. Kalkan, T. Kahraman, BO. Ugut, B. Donmez Colakoglu, A. Genc (Izmir, Turkey)

    Objective: To compare balance and gait parameters between subtypes of Parkinson's disease (PD). Background: PD, which is a progressive neurodegenerative disease, has different clinical courses…
  • 2019 International Congress

    Neuroprotective effect of Lemon oil on 6-OHDA-Induced Apoptosis in PC12 Cells through the ROS-NO Pathway

    V. Kumar (Allahabad, India)

    Objective: The objective of current investigation was to decipher e the neuroprotective effect of lemon oil (LO) on PC 12 cell lines by 6-hydroxydopamine (6-OHDA)…
  • « Previous Page
  • 1
  • …
  • 129
  • 130
  • 131
  • 132
  • 133
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #22901 (not found)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley